These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32409195)

  • 1. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
    de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
    Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):36-41. PubMed ID: 32409195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
    Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
    Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the cancer risk management model lung cancer screening module.
    Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
    Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
    Pastorino U; Silva M; Sestini S; Sabia F; Boeri M; Cantarutti A; Sverzellati N; Sozzi G; Corrao G; Marchianò A
    Ann Oncol; 2019 Jul; 30(7):1162-1169. PubMed ID: 30937431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
    Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
    Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis.
    Su CC; Wu JT; Neal JW; Popat RA; Kurian AW; Backhus LM; Nagpal S; Leung AN; Wakelee HA; Han SS
    J Thorac Oncol; 2021 Sep; 16(9):1479-1489. PubMed ID: 34091050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
    Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
    Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
    Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
    Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low positive predictive value of computed tomography screening for lung cancer irrespective of commonly employed definitions of target population.
    Krilaviciute A; Brenner H
    Int J Cancer; 2021 Jul; 149(1):58-65. PubMed ID: 33634860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
    National Lung Screening Trial Research Team
    J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation.
    Tanner NT; Gebregziabher M; Hughes Halbert C; Payne E; Egede LE; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jul; 192(2):200-8. PubMed ID: 25928649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.